Showing results (41-50 of 103) with videos related to
Sort By:
Pageof 11
Journal of Radiation Research|October 27, 2014
Treatment outcomes using CyberKnife for brain metastases from lung cancerKeisuke Tamari, Osamu Suzuki, Naoya Hashimoto, et al.Journal of Neuro-Oncology|November 2, 2023
Qualitative MR features to identify non-enhancing tumors within glioblastoma's T2-FLAIR hyperintense lesionsShota Yamamoto, Yoshiko Okita, Hideyuki Arita, et al.Surgical Neurology|June 7, 2005
Immunohistochemical detection of female sex hormone receptors in craniopharyngiomas: correlation with clinical and histologic featuresShuichi Izumoto, Tsuyosi Suzuki, Manabu Kinoshita, et al.International Journal of Clinical Oncology|December 8, 2010
A survey of disclosure of diagnosis to patients with glioma in JapanFukuko Yamamoto, Naoya Hashimoto, Naoki Kagawa, et al.BMC Medical Education|August 3, 2025
Integration of early clinical exposure into curriculum enhances self-assessment of professional competencies in medical practiceTsuyoshi Oshiro, Shintaro Suzuki, Naoki Kagawa, et al.Journal of Neurosurgery|December 20, 2011
Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studiesNaoya Hashimoto, Carter S Rabo, Yoshiko Okita, et al.Japanese Journal of Clinical Oncology|April 6, 2010
Effects of concomitant temozolomide and radiation therapies on WT1-specific T-cells in malignant gliomaYasuyoshi Chiba, Naoya Hashimoto, Akihiro Tsuboi, et al.Journal of Neurosurgery|February 27, 2016
Comparison of diffusion tensor imaging and <sup>11</sup>C-methionine positron emission tomography for reliable prediction of tumor cell density in gliomasManabu Kinoshita, Hideyuki Arita, Yoshiko Okita, et al.Oncology Letters|November 4, 2024
Dynamic susceptibility contrast‑enhanced perfusion magnetic resonance imaging parameters for predicting <i>MGMT</i> promoter methylation and prognostic value in newly diagnosed patients with glioblastomaDaiki Chida, Yoshiko Okita, Reina Utsugi, et al.Japanese Journal of Clinical Oncology|June 20, 2013
Hypofractionated stereotactic radiation therapy in three to five fractions for vestibular schwannomaMasahiro Morimoto, Yasuo Yoshioka, Tadayuki Kotsuma, et al.Pageof 11